151 related articles for article (PubMed ID: 35616981)
21. Irradiation impairment of umami taste in patients with head and neck cancer.
Shi HB; Masuda M; Umezaki T; Kuratomi Y; Kumamoto Y; Yamamoto T; Komiyama S
Auris Nasus Larynx; 2004 Dec; 31(4):401-6. PubMed ID: 15571914
[TBL] [Abstract][Full Text] [Related]
22. Posttreatment quality-of-life assessment in patients with head and neck cancer treated with intensity-modulated radiation therapy.
O'Neill M; Heron DE; Flickinger JC; Smith R; Ferris RL; Gibson M
Am J Clin Oncol; 2011 Oct; 34(5):478-82. PubMed ID: 21537150
[TBL] [Abstract][Full Text] [Related]
23. Taste dysfunction following radiotherapy to the head and neck: A systematic review.
Gunn L; Gilbert J; Nenclares P; Soliman H; Newbold K; Bhide S; Wong KH; Harrington K; Nutting C
Radiother Oncol; 2021 Apr; 157():130-140. PubMed ID: 33545253
[TBL] [Abstract][Full Text] [Related]
24. Taste disorders following cancer treatment: report of a case series.
Epstein JB; de Andrade E Silva SM; Epstein GL; Leal JHS; Barasch A; Smutzer G
Support Care Cancer; 2019 Dec; 27(12):4587-4595. PubMed ID: 30927113
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
26. Patterns of dysphagia and acute toxicities in patients with head and neck cancer undergoing helical IMRT±concurrent chemotherapy.
Moroney LB; Helios J; Ward EC; Crombie J; Wockner LF; Burns CL; Spurgin AL; Blake C; Kenny L; Hughes BG
Oral Oncol; 2017 Jan; 64():1-8. PubMed ID: 28024718
[TBL] [Abstract][Full Text] [Related]
27. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
Jabbari S; Kim HM; Feng M; Lin A; Tsien C; Elshaikh M; Terrel JE; Murdoch-Kinch C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):725-31. PubMed ID: 16199308
[TBL] [Abstract][Full Text] [Related]
28. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
29. Late term tolerance in head neck cancer patients irradiated in the IMRT era.
Studer G; Linsenmeier C; Riesterer O; Najafi Y; Brown M; Yousefi B; Bredell M; Huber G; Schmid S; Studer S; Zwahlen R; Rordorf T; Glanzmann C
Radiat Oncol; 2013 Nov; 8():259. PubMed ID: 24192223
[TBL] [Abstract][Full Text] [Related]
30. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Youssef I; Yoon J; Mohamed N; Zakeri K; Press RH; Chen L; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Yu Y; Cohen MA; Dunn LA; Ho AL; Wong RJ; Michel LS; Boyle JO; Singh B; Kriplani A; Ganly I; Sherman EJ; Pfister DG; Fetten J; Lee NY
JAMA Netw Open; 2022 Nov; 5(11):e2241538. PubMed ID: 36367724
[TBL] [Abstract][Full Text] [Related]
31. Impact of radiation dose on patient-reported acute taste alteration in a prospective observational study cohort in head and neck squamous cell cancer (HNSCC).
Morelli I; Desideri I; Romei A; Scoccimarro E; Caini S; Salvestrini V; Becherini C; Livi L; Bonomo P
Radiol Med; 2023 Dec; 128(12):1571-1579. PubMed ID: 37642816
[TBL] [Abstract][Full Text] [Related]
32. Oral complications at 6 months after radiation therapy for head and neck cancer.
Lalla RV; Treister N; Sollecito T; Schmidt B; Patton LL; Mohammadi K; Hodges JS; Brennan MT;
Oral Dis; 2017 Nov; 23(8):1134-1143. PubMed ID: 28675770
[TBL] [Abstract][Full Text] [Related]
33. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
34. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
Beetz I; Schilstra C; van der Schaaf A; van den Heuvel ER; Doornaert P; van Luijk P; Vissink A; van der Laan BF; Leemans CR; Bijl HP; Christianen ME; Steenbakkers RJ; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):101-6. PubMed ID: 22516776
[TBL] [Abstract][Full Text] [Related]
35. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia?
Roe JW; Drinnan MJ; Carding PN; Harrington KJ; Nutting CM
Oral Oncol; 2014 Dec; 50(12):1182-7. PubMed ID: 25448227
[TBL] [Abstract][Full Text] [Related]
36. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma.
Daly ME; Lieskovsky Y; Pawlicki T; Yau J; Pinto H; Kaplan M; Fee WE; Koong A; Goffinet DR; Xing L; Le QT
Head Neck; 2007 Mar; 29(3):211-20. PubMed ID: 17111429
[TBL] [Abstract][Full Text] [Related]
38. Oral examination findings, taste and smell testing during and following head and neck cancer therapy.
Epstein JB; Villines D; Epstein GL; Smutzer G
Support Care Cancer; 2020 Sep; 28(9):4305-4311. PubMed ID: 31912362
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
40. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.
Lee TF; Yeh SA; Chao PJ; Chang L; Chiu CL; Ting HM; Wang HY; Huang YJ
Radiat Oncol; 2015 Sep; 10():194. PubMed ID: 26377924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]